SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 12.09 |
Enterprise Value ($M) | 8.23 |
Book Value ($M) | 35.52 |
Book Value / Share | 1.07 |
Price / Book | 0.34 |
NCAV ($M) | 35.50 |
NCAV / Share | 1.07 |
Price / NCAV | 0.34 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.25 |
Return on Assets (ROA) | -0.95 |
Return on Equity (ROE) | -1.11 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.45 |
Current Ratio | 4.45 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 45.80 |
Assets | 45.82 |
Liabilities | 10.30 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -83.89 |
Net Income | -79.98 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -51.76 |
Cash from Investing | 51.56 |
Cash from Financing | -0.04 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Squadron Capital Management LLC | 6.20 | ||
13G/A | Deep Track Capital, LP | 2.24 | -66.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
117,389 | 370,657 | 31.67 | |
203,217 | 580,777 | 34.99 | |
196,623 | 607,724 | 32.35 | |
102,878 | 659,629 | 15.60 | |
(click for more detail) |
Similar Companies | |
---|---|
RGEN – Repligen Corporation | RGNX – REGENXBIO Inc. |
RIGL – Rigel Pharmaceuticals, Inc. | RLYB – Rallybio Corporation |
ROIV – Roivant Sciences Ltd. |
Financial data and stock pages provided by
Fintel.io